scholarly article | Q13442814 |
P2093 | author name string | Li Liu | |
Lin Xie | |||
Xiang Liu | |||
Xiaodong Liu | |||
Guangji Wang | |||
Xinting Wang | |||
Yunli Yu | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1000-1006 | |
P577 | publication date | 2009-11-27 | |
P1433 | published in | Biochemical Pharmacology | Q864229 |
P1476 | title | Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies | |
P478 | volume | 79 |
Q50847602 | A grape seed extract increases active glucagon-like peptide-1 levels after an oral glucose load in rats |
Q33689169 | AMPK activation--protean potential for boosting healthspan |
Q43635628 | Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats |
Q35226998 | Application of berberine on treating type 2 diabetes mellitus |
Q50243185 | Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study. |
Q28477076 | Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis |
Q49834498 | Berberine activates bitter taste responses of enteroendocrine STC-1 cells |
Q50932207 | Berberine ameliorates collagen-induced arthritis in rats by suppressing Th17 cell responses via inducing cortistatin in the gut. |
Q38326750 | Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies |
Q50746082 | Berberine chloride improved synaptic plasticity in STZ induced diabetic rats. |
Q64084960 | Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics |
Q33671672 | Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels |
Q84419413 | Berberine, an Isoquinoline Alkaloid in Herbal Plants, Protects Pancreatic Islets and Serum Lipids in Nonobese Diabetic Mice |
Q37914665 | Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease |
Q55274553 | Cellular stress response mechanisms of Rhizoma coptidis: a systematic review. |
Q39234994 | Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats |
Q64064784 | Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology |
Q46307017 | Could hop-derived bitter compounds improve glucose homeostasis by stimulating the secretion of GLP-1? |
Q38525666 | Effects of flavanols on the enteroendocrine system: Repercussions on food intake |
Q39039552 | Grape-seed procyanidins modulate cellular membrane potential and nutrient-induced GLP-1 secretion in STC-1 cells |
Q60948754 | Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress |
Q31123158 | Identification of the metabolites of anti-inflammatory compound clematichinenoside AR in rat intestinal microflora |
Q39187894 | Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides |
Q53130900 | Interaction of Herbal Compounds with Biological Targets: A Case Study with Berberine |
Q36516516 | Modulating gut microbiota as an anti-diabetic mechanism of berberine |
Q49325511 | Natural products, an important resource for discovery of multitarget drugs and functional food for regulation of hepatic glucose metabolism |
Q38364477 | Possible abilities of dietary factors to prevent and treat diabetes via the stimulation of glucagon-like peptide-1 secretion |
Q84643006 | Possible therapeutic potential of berberine in diabetic osteopathy |
Q37638836 | Protection of long-term treatment with huang-lian-jie-du-tang on vascular endothelium in rats with type 2 diabetes mellitus |
Q58700647 | Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice |
Q37798050 | Targeting metabolic syndrome: Candidate natural agents |
Q28546885 | Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model |
Q37355794 | Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. |
Q37851981 | Toward a new age of cellular pharmacokinetics in drug discovery |
Q34974868 | Traditional Chinese Medicines in Treatment of Patients with Type 2 Diabetes Mellitus |
Q39562298 | Treatment of Diabetes Using Traditional Chinese Medicine: Past, Present and Future |
Q33842742 | Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets |